Agilent Technologies Inc vs SoundHound AI Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while SoundHound AI Inc trades at $7.43 (market cap $3.25B). The key difference: Agilent Technologies Inc is far larger — about 12.9× SoundHound AI Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.
| A | SOUN | |
|---|---|---|
Market Cap | $42.00B | $3.25B |
Sector | Health | Technology |
52-Week High | $157.20 | $21.40 |
52-Week Low | $110.24 | $5.70 |
Enterprise Value | $43.55B | $3.05B |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SoundHound AI (SOUN) trades at $8.02, up 13.28% today, showing strong momentum after beating Q2 2026 earnings expectations. The stock maintains a bullish technical signal with support at $7 and resistance at $9. Revenue grew 45% last quarter to $61.9M, though the company remains unprofitable with a -67.45% net margin. Analyst consensus is strongly bullish with 75% buy ratings and an $8.50 price target.
SOUN offers growth potential through its OASYS platform expansion and enterprise adoption, but faces significant execution risks from persistent losses, cash burn, and premium valuation. The stock's near-term trajectory depends on continued revenue acceleration and path to profitability. High valuation multiples and negative cash flow present challenges despite strong analyst support.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →